ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis

Biochemical Pharmacology
L Aragoneses-FenollJosè Maria Rojo

Abstract

Class IA phosphoinositide 3-kinases (PI3K) are essential to function of normal and tumor cells, and modulate immune responses. T lymphocytes express high levels of p110α and p110δ class IA PI3K. Whereas the function of PI3K p110δ in immune and autoimmune reactions is well established, the role of p110α is less well understood. Here, a novel dual p110α/δ inhibitor (ETP-46321) and highly specific p110α (A66) or p110δ (IC87114) inhibitors have been compared concerning T cell activation in vitro, as well as the effect on responses to protein antigen and collagen-induced arthritis in vivo. In vitro activation of naive CD4(+) T lymphocytes by anti-CD3 and anti-CD28 was inhibited more effectively by the p110δ inhibitor than by the p110α inhibitor as measured by cytokine secretion (IL-2, IL-10, and IFN-γ), T-bet expression and NFAT activation. In activated CD4(+) T cells re-stimulated through CD3 and ICOS, IC87114 inhibited Akt and Erk activation, and the secretion of IL-2, IL-4, IL-17A, and IFN-γ better than A66. The p110α/δ inhibitor ETP-46321, or p110α plus p110δ inhibitors also inhibited IL-21 secretion by differentiated CD4(+) T follicular (Tfh) or IL-17-producing (Th17) helper cells. In vivo, therapeutic administration of ETP-463...Continue Reading

References

Mar 1, 1996·Analytical Chemistry·A ShevchenkoM Mann
Jun 8, 2001·Annual Review of Biochemistry·B VanhaesebroeckM D Waterfield
Jul 23, 2003·Trends in Pharmacological Sciences·Matthias P WymannMuriel Laffargue
Nov 14, 2003·The New England Journal of Medicine·Joel M KremerLarry W Moreland
May 10, 2005·The Journal of Biological Chemistry·Hyoung-Pyo KimWarren J Leonard
Jan 9, 2007·Trends in Immunology·Klaus OkkenhaugBart Vanhaesebroeck
Feb 10, 2007·Nature Reviews. Immunology·Christian RommelHong Ji
Sep 14, 2007·Arthritis Research & Therapy·Viviana LutzkyRanjeny Thomas
Oct 30, 2007·Autoimmunity·H FengS Yoshino
Sep 17, 2008·Oncogene·L Zhao, P K Vogt
Nov 5, 2008·The Journal of Experimental Medicine·Jared M OdegardJoe Craft
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jason A BubierDerry C Roopenian
Mar 18, 2009·Immunological Reviews·David A Fruman, Georges Bismuth
Nov 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mathieu GigouxWoong-Kyung Suh
Feb 16, 2010·Nature Reviews. Immunology·Margarida Saraiva, Anne O'Garra
Apr 10, 2010·Nature Reviews. Molecular Cell Biology·Bart VanhaesebroeckBenoit Bilanges
Aug 21, 2010·Nature Reviews. Immunology·Martin R Müller, Anjana Rao
Dec 29, 2010·Cellular and Molecular Life Sciences : CMLS·Yenny Y AcostaJose M Rojo
Jan 18, 2012·Biology Direct·Neil S GreenspanSteven N Emancipator
Mar 1, 2012·The Biochemical Journal·Lomon So, David A Fruman
Mar 22, 2012·The American Journal of Pathology·Beatrix BartokGary S Firestein
Apr 24, 2012·Bioorganic & Medicinal Chemistry Letters·Sonia Martínez GonzálezJoaquín Pastor
Jul 4, 2012·Nature Immunology·Francisco J QuintanaVijay K Kuchroo
Oct 23, 2012·Frontiers in Immunology·Christopher J Gamper, Jonathan D Powell
Nov 6, 2012·Current Opinion in Immunology·Rebecca A SweetCarola G Vinuesa

❮ Previous
Next ❯

Citations

Mar 23, 2018·The Journal of Pharmacology and Experimental Therapeutics·Tao YangDan M Roden
Jul 10, 2019·PloS One·María Montes-CasadoPilar Portolés
Jul 3, 2021·International Journal of Molecular Sciences·María Montes-CasadoPilar Portolés

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.